Doccla was proud to participate in the EU-funded MedSecurance project, a landmark initiative designed to redefine cybersecurity and assurance standards for the Internet of Medical Things (IoMT). As a ...

Europe’s virtual hospital closes fresh funding to increase presence in Life Sciences.

Hospitals around the world regularly face bed shortages — an issue that can get exacerbated to breaking point when a health scare or other large-scale disaster occurs. A startup called Doccla is bringing technology to bear address the issue: it’s building…

Europe’s Virtual Hospital Raises Fresh Funds to Accelerate European Expansion, with Focus on Germany Leading virtual ward technology provider Doccla has received a strategic investment of €5 million Euro from Bertelsmann Investments, the global venture…

Hospitals around the world regularly face bed shortages -- an issue that can get exacerbated to breaking point when a health scare or other large-scale

A technology company has entered a 'landmark partnership' with NHS Greater Glasgow and Clyde to build the 'virtual hospital of the future'

The health board has agreed a partnership with Doccla, which already provides virtual care solutions to NHS Lanarkshire and Trusts in England, to enable more patients to receive medical support from the comfort of their own homes.

Remote: Full Remote Contract: Full time Experience: Senior (5-10 years) Work from: United Kingdom A bit about us We’re Doccla, the virtual ward company. We provide patients and clinicians with the transformative power of remote patient monitoring. Our ...

The government has pledged to move NHS care towards the community, digital and prevention. An HSJ webinar, in association with Doccla, looked at work some NHS organisations were already doing which co...

The government has pledged to move NHS care towards the community, digital and prevention. An HSJ webinar, in association with Doccla, looked at work some NHS organisations were already doing which co...

AbstractObjectivesUp to 25% of patients receiving OPAT will develop a complication of their infection or treatment, requiring unplanned assessment or admission. In our institution, patients attending daily for IV antibiotics, or receiving home administration by district nurses, routinely have daily monitoring of their vital signs. However, patients who are self-administering (or having antibiotics administered by a carer) do not have daily observations. In this pilot study, we assessed the advantages and disadvantages of a novel system for remote monitoring of vital signs in the patient’s home.MethodsA remote monitoring system known as DOCCLA was used. Patients were given equipment for home measurement of blood pressure, pulse, temperature, respiratory rate and oxygen saturation. They were asked to complete observations and a questionnaire daily regarding their symptoms. Results were returned electronically to a team of clinicians who were available 24/7 to respond to abnormal observations or change in symptoms. Where necessary, these clinicians contacted the patient direct and arranged acute interventions.ResultsFifteen patients on IV antibiotics via OPAT were referred for remote monitoring, of whom 13 submitted observations and questionnaire responses. A median of 17.5% (range 6.6-24.2) of clinical observations were flagged as outside predefined reference ranges. None of these led to urgent in-person clinical review. Patients reported a range of symptoms, including pain, nausea, dizziness, constipation and malaise. No patients required urgent in-person review due to symptoms reported on the daily questionnaire. One patient contacted the clinical team out of hours as she felt unwell. She was referred urgently to a hospital assessment unit but did not require admission. Anonymized patient feedback demonstrated that patients felt reassured by regular monitoring of vital signs and availability of clinicians for advice and support 24/7. Many reported initial apprehension in setting up and using the system, however, were pleased that they were able to do this successfully. Some patients felt anxious at abnormal observation results when they were feeling well. Some logistic issues with the service were also reported.ConclusionsIn this pilot study, patients were generally supportive of the system for daily clinical observations and symptom monitoring and felt reassured by having 24/7 direct access to clinical support, something that most OPAT services are unable to provide. However, flagged observation results were generally non-significant and generated workload for the clinical team and anxiety for patients. Further work is needed to develop a more personalized approach to reference ranges for observations, and to determine which OPAT patient groups are most likely to benefit from remote monitoring.